We assume that students who are learning clinical medicine already possess an understanding of the basic principles of human genetics. Clinical training provides students with an opportunity to apply their understanding of these principles to the diagnosis, management and prevention of human disease. Learning medical genetics is a process that should continue throughout a physician's career. Medical students should gain cognitive mastery of the objectives listed below during clinical training. Subsequent postgraduate training should provide appropriate experience in the application of these objectives in primary care or a particular medical specialty.
Medical genetics is a recognized clinical specialty as well as an extensive field of knowledge that provides a unique perspective on function of the human body in health and disease. It is, therefore, essential that a well-qualified medical geneticist (or small committee of medical geneticists) be given the authority and responsibility for implementing the clinical genetics curriculum at each medical school. We recognize that curricula, resources and personnel available for teaching medical genetics differ greatly among medical schools. The objectives included here can be taught in various clinical contexts and at different points in clinical training, depending on the particular circumstances at each school.
During their training, medical students must acquire many general skills and attitudes that are important in all aspects of clinical practice, including medical genetics. These general competencies include the ability of students to:
Medical genetics is one of the most rapidly advancing areas of medical practice. The knowledge of medical genetics that is necessary for medical practice is likely to be very different in 10 or 20 years than it is now. The Association of Professors welcomes all comments on these objectives, which we shall revise as necessary to reflect changes that occur in our understanding of genetics and its application to clinical medicine.
| 1.1 | how genetic factors predispose to mendelian and multifactorial diseases and the implications of such predispositions for disease diagnosis, treatment and prevention; |
| 1.2 | the clinical manifestations of common mendelian diseases; |
| 1.3 | the clinical features of common chromosomal aneuploidies and the signs generally associated with other kinds of chromosomal imbalance; |
| 1.4 | how constitutional and acquired genetic alterations can lead to the development of malignant neoplasms and how identification of these changes can be used in the diagnosis, management and prevention of malignancy; |
| 1.5 | how knowledge of a patient's genotype can be used to develop a more effective approach to health maintenance, disease diagnosis, and treatment for that particular individual; |
| 1.6 | the procedures that are generally employed for prenatal genetic diagnosis and the indications for such testing; |
| 1.7 | the advantages, limitations, and disadvantages of presymptomatic testing for genetic disease; |
| 1.8 | the existence of and justification for screening programs to detect genetic disease, and the difference between screening and more definitive testing; |
| 1.9 | the differences in goals and approach among screening programs for genetic diseases in newborn infants, pregnant women, and other adults; |
| 1.10 | conventional approaches to treatment of genetic diseases and the general status of gene-based therapies; |
| 1.11 | what exposures are likely to be teratogenic in humans and how such exposures can be prevented; |
| 1.12 | indications and appropriate methods for referral of individuals with a genetic disease or congenital anomaly to medical genetics specialists; |
| 1.13 | how novel scientific discoveries are evaluated in a clinical context and applied appropriately to the care of patients; and |
| 1.14 | how legal and ethical issues related to genetics affect general medical practice. |
| 2.1 | elicit a comprehensive family medical history, construct an appropriate medical pedigree, and recognize patterns of inheritance and other signs suggestive of genetic disease in the family history; |
| 2.2 | recognize features in a patient's medical history, physical examination or laboratory investigations that suggest the presence of genetic disease; |
| 2.3 | identify patients with strong inherited predispositions to common diseases and facilitate appropriate assessment of other at-risk family members; |
| 2.4 | recognize and classify common congenital anomalies and patterns of anomalies; |
| 2.5 | recognize and initiate the evaluation of patients with inborn errors of metabolism; |
| 2.6 | use common cytogenetic, molecular genetic, and biochemical genetic diagnostic techniques efficiently; |
| 2.7 | estimate recurrence risks within an affected family for diseases transmitted as uncomplicated mendelian or multifactorial traits; |
| 2.8 | use the information that a patient has a genetic predisposition for a particular disease to help him or her reduce the risk of developing that disease or deal with it more effectively if it does develop; |
| 2.9 | describe appropriate techniques and approaches to providing genetic counseling for commonly-encountered genetic diseases; |
| 2.10 | communicate genetic information in a manner that is suitable for individuals of various different educational and cultural backgrounds; and |
| 2.11 | work with a medical genetics specialist to develop a comprehensive plan for the evaluation and management of patients with genetic disease. |